Integer Holdings Corp (ITGR): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-30, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$49.50M
Year ended 2025-12-31
$48.58M
Trailing 12 months to 2026-07-03
-6.1%
3-year compound annual growth
$61.97M2010-01-01: $33.56M2010-12-31: $45.02M2011-12-30: $45.51M2012-12-28: $52.49M2014-01-03: $54.08M2015-01-02: $49.84M2016-01-01: $52.99M2016-12-30: $47.90M2017-12-29: $48.85M2018-12-28: $48.60M2019-12-31: $46.53M2020-12-31: $48.47M2021-12-31: $51.98M2022-12-31: $59.76M2023-12-31: $61.97M2024-12-31: $53.42M2025-12-31: $49.50M$49.50M
2010-01-01 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$49.50M-7.3%2026-02-23, From 2025-01-01
2024-12-31$53.42M-13.8%2026-02-23, From 2024-01-01
2023-12-31$61.97M+3.7%2026-02-23, From 2023-01-01
2022-12-31$59.76Mn/c2025-02-20, From 2022-01-01
2021-12-31$51.98M+7.3%2024-02-20, From 2021-01-01
2020-12-31$48.47M+4.2%2023-02-21, From 2020-01-01
2019-12-31$46.53M-4.3%2022-02-22, From 2018-12-29
2018-12-28$48.60M-0.5%2021-02-18, From 2017-12-30
2017-12-29$48.85M+2.0%2020-02-20, From 2016-12-31
2016-12-30$47.90Mn/c2019-02-22, From 2016-01-02
2016-01-01, Fiscal 2015$52.99M+6.3%2018-02-22, From 2015-01-03
2015-01-02, Fiscal 2014$49.84M-7.8%2017-02-28, From 2014-01-04
2014-01-03, Fiscal 2013$54.08M+3.0%2016-03-01, From 2012-12-29
2012-12-28$52.49M+15.3%2015-03-03, From 2011-12-31
2011-12-30$45.51M+1.1%2014-03-04, From 2011-01-01
2010-12-31$45.02M+34.1%2013-02-27, From 2010-01-02
2010-01-01, Fiscal 2009$33.56Mn/a2012-02-28, From 2009-01-03

R&D Expense at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Integer Holdings Corp (ITGR)2025-12-31$49.50M-7.3%
LivaNova PLC (LIVN)2025-12-31$185.76M+1.8%
Conmed Corp (CNMD)2025-12-31$55.88M+2.7%
TransMedics Group, Inc. (TMDX)2025-12-31$69.06M+23.4%
InMode Ltd. (INMD)2025-12-31$13.32M+1.4%
Axogen, Inc. (AXGN)2025-12-31$32.88M+18.4%
Outset Medical, Inc. (OM)2025-12-31$21.23M-44.7%
Biolife Solutions Inc (BLFS)2025-12-31$7.57M+59.3%
Medtronic plc (MDT)2026-04-24$2.87B+5.2%

Compare ITGR, LIVN, CNMD, TMDX side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗